Publications
103
Citations
1,481
Est. group size
—
Recurring co-author estimate
Active years
15
Publishing since 2012
Mahmoud Kallash's work focuses on kidney diseases in children and adults, including nephrotic syndrome, focal segmental glomerulosclerosis, lupus nephritis, and blood pressure management in chronic kidney disease. Some of his recent output also includes review articles on cardiovascular disease treatments, suggesting involvement in broader clinical topic reviews alongside his core kidney-disease research. This body of work is largely clinical, drawing on multicenter and cohort studies to examine treatment outcomes and biomarkers.
Publication output has grown fairly steadily over the last decade, rising from about 4 papers per year in 2017 to a peak of 20 in 2025, with an average of 12 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The Potential Role of Anti-Inflammatory Therapy in Heart Failure Treatment
Cardiology in Review · 2026
- Clinical presentations, treatments, and outcomes of pediatric lupus nephritis: a prospective cohort study from the Pediatric Nephrology Research Consortium
Pediatric Nephrology · 2026
- Contemporary Treatment Responses of Recurrent Focal Segmental Glomerulosclerosis or Steroid Resistant Nephrotic Syndrome in Children after Kidney Transplantation: Phase 2 of a Multicenter Electronic Health Record Data Analysis
Research Square · 2026
- Blood Pressure Control in Adolescents With CKD and Risk of Kidney Failure in Young Adulthood
Kidney Medicine · 2026
- Rituximab improves the control of pediatric nephrotic syndrome and reduces healthcare utilization
Clinical Nephrology · 2026
- Blood Pressure Control in Adolescents With CKD and Risk of Kidney Failure in Young Adulthood.
UNC Libraries · 2026
- Cardiovascular Syphilis
Cardiology in Review · 2025
- Omecamtiv mecarbil, a cardiac myosin activator with potential efficacy in heart failure
Archives of Medical Science - Atherosclerotic Diseases · 2025
- Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental Glomerulosclerosis
Kidney Medicine · 2025
- Vericiguat, a Soluble Guanylate Cyclase Stimulator Approved for Heart Failure Treatment
Cardiology in Review · 2025
- Continuation Versus Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Undergoing Noncardiac Surgery
Cardiology in Review · 2025
- Transthyretin Amyloid Cardiomyopathy: A Review of Approved Pharmacotherapies
Cardiology in Review · 2025
- The Cardiovascular Benefits of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
Cardiology in Review · 2025
- Investigating the Physiologic Role of Leptin and Its Relationship to Obesity
Cardiology in Review · 2025
- Investigating the Relationship Between Sodium–Glucose Cotransporter-2 (SGLT2) Inhibitors and Blood Pressure
Cardiology in Review · 2025
- Pediatric Nephrology×16
- Cardiology in Review×12
- Journal of the American Society of Nephrology×12
- American Journal of Kidney Diseases×5
- Kidney International Reports×4
- William E. Smoyer
Medicine · The Ohio State University
- Salem Almaani
Medicine · The Ohio State University
- Clarissa A. Cassol
Medicine · The Ohio State University
- Jorge Rojas-Rivera
Medicine · The Ohio State University
- Brad H. Rovin
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile